Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS)
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS)
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765
New data on aggressive B cell lymphoma
Update on the phase III VISTA trial
Treatment of breast cancer as a chronic disease
Everolimus improved PFS in advanced hormone receptor positive breast cancer
Anaemia management update: blood transfusion and ESA use in oncology
Translational research and proteasome inhibitors in multiple myeloma
Advances in the treatment of T-cell lymphoma
Key research from the 9th International Workshop for Lymphoma
Active angiogenesis drugs in development
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer